Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Study of Pevonedistat in Combination With Carboplatin and Paclitaxel in Advanced Intrahepatic Cholangiocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04175912
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:59.030963+00:00
Published At
2025-01-07T00:00:00+00:00
Record Updated At
2025-11-17
Results Posted At
2025-01-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Metastatic Cholangiocarcinoma", "Metastatic Hepatocellular Carcinoma", "Stage III Hepatocellular Carcinoma AJCC v8", "Stage III Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IIIA Hepatocellular Carcinoma AJCC v8", "Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IIIB Hepatocellular Carcinoma AJCC v8", "Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IV Hepatocellular Carcinoma AJCC v8", "Stage IV Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IVA Hepatocellular Carcinoma AJCC v8", "Stage IVB Hepatocellular Carcinoma AJCC v8", "Unresectable Cholangiocarcinoma", "Unresectable Hepatocellular Carcinoma", "Unresectable Intrahepatic Cholangiocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-17"
protocolSection.identificationModule.nctId
"NCT04175912"
protocolSection.identificationModule.officialTitle
"A Phase 2 Study of Pevonedistat in Combination With Carboplatin and Paclitaxel in Advanced Intrahepatic Cholangiocarcinoma"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-01-07"

Study condition terms

  • Metastatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Intrahepatic Cholangiocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Intrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.